Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP
MBV was an independent prognostic factor for DLBCL patients. The combination of MBV with parameters reflecting tumor dissemination distribution or total tumor burden further improved the risk stratification for staging in DLBCL patients.
Authors
- Yuxiao Hu (ORCID: https://orcid.org/0000-0003-3520-6634)
- Panpan Luan
- Silu Cui
- Qi Jiang
Institutions
- Nanjing University of Chinese Medicine (CN)
- Jiangsu Cancer Hospital (CN)
- Jiangsu Province Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.3389/fonc.2026.1747186
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00